Venus Remedies has entered into a collaborative agreement with Israel-based generic drug maker Teva for selling an anti- cancer drug in the Canadian market. The drug is widely used for the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
04:21
Unknown
Posted in:
0 comments:
Post a Comment